echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Borui Pharmaceuticals: Oxiracetam injection obtained drug registration certificate

    Borui Pharmaceuticals: Oxiracetam injection obtained drug registration certificate

    • Last Update: 2021-03-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 18, Borui Pharmaceuticals issued an announcement stating that Borui Pharmaceuticals, a wholly-owned subsidiary, received the "Oxiracetam Injection" and "Drug Registration Certificate" approved and issued by the State Drug Administration.


    It is reported that the indications of Oxiracetam injection are: it is suitable for the treatment of brain injury and the neurological deficit, memory and intellectual impairment caused by it.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.